Discngine Labs Live: Navigating Developability Challenges Across Antibody Modalities: Computational Tools & Approaches
Join us in Basel, Switzerland, for the next Discngine Labs Live event on:
Navigating Developability Challenges Across Antibody Modalities: Computational Tools & Approaches
Discover how computational tools are supporting scientists in addressing developability challenges for traditional and next-generation antibody therapeutics, and take the opportunity to connect with peers from both industry and academia.
The event will take place in person and will also be streamed online!
About the event
The biopharmaceutical landscape is evolving rapidly, with increasingly complex antibody modalities such as multispecifics and antibody–drug conjugates (ADCs) pushing the boundaries of therapeutic design.
While these innovative formats offer new treatment possibilities, they also introduce greater developability challenges, including increased aggregation risks and higher viscosity, poor solubility, and reduced stability.
So, how are in-silico developability practices adapting to support both traditional monoclonal antibodies (mAbs) and next-generation antibody formats?
At this scientific gathering, you will discover innovative in silico approaches and practical workflows that support predictive assessment of key physicochemical properties across mAbs and advanced modalities early in the discovery process; ultimately guiding a rational construct design and reducing downstream risks related to formulation and manufacturability.
What to expect?
Scientific talks from pharma researchers sharing their latest discoveries and in-silico workflows for mitigating developability risks
An expert panel providing insights and best practices for early developability assessment, featuring both early and late-stage experts
Networking opportunities with industry peers and casual discussions over food and drinks
Watch the replay!
Discngine Labs Live: Setting New Standards in SBDD: Experimental and Predicted Protein Structure Synergies
Watch the replay of the 10th Special Edition of Discngine Labs — Discngine’s free event series on early drug discovery - held in person for the very first time in Cambridge, UK!
Discngine Labs: FAIR-enabled Sample Management with Discngine Assay
Learn from our expert how embracing digital transformation and adhering to FAIR principles can significantly enhance your sample management processes.
Discngine Labs: The Future of Bioassay Data - A FAIR Implementation Discussion
Join us on November 28th at 16:00 CET for an insightful event that will dive into the world of FAIR (Findable, Accessible, Interoperable, and Reusable) implementation and value for bioassay data.
Discngine Labs: Harnessing the Potential of Structural Data for Ideation in Drug Discovery
In our sixth Discngine Labs, after a brief demo of 3decision, pharma experts in the field will discuss the critical aspects of efficient structural data management for new compound designs.
Watch the replay now!
Discngine Labs: Predicting Antibody Developability - In silico & In vitro synergies
The fifth Discngine Labs will provide insights on how to successfully develop therapeutic antibodies using a combination of in silico and in vitro approaches. Discover strategies for combining these two methodologies, which lead our speakers to improved predictions and increased efficiency in antibody development.
Register now to watch the roundtable and get the opportunity to meet the speakers during our networking session.
Discngine Labs: Protein structure prediction - What’s next after AlphaFold?
In our fourth Discngine Labs, experts from both pharma and academia will present how they use AlphaFold and other machine-learning-based technologies to develop methods that predict protein structures more suitable for drug discovery applications.
Register now to access the presentations and meet the speakers at the networking session in our virtual bar
Discngine Labs: The future of Cryo-EM in Pharma
Discngine Labs is our new exciting networking event to connect Discngine customers, partners and everyone interested in innovative solutions for data-driven decision-making in pharma and biotech R&D. Join us at our interactive virtual office and labs to network and exchange (almost as in real life)!
In our third Discngine Labs you will have the chance to hear about the opportunities and limitations of cryo-electron microscopy (Cryo-EM) in drug discovery projects. Industry experts from various companies (Sanofi, Boehringer Ingelheim, NanoImaging Services, Thermo Fischer Scientific) will engage in a thoughtful roundtable discussion, sharing their experiences and perspectives about Cryo-EM potential for structure-based drug discovery.
Discngine Labs: Virtual Reality for Structure-Based Drug Discovery
Discngine Labs is our new exciting networking event to connect Discngine customers, partners and everyone interested in innovative solutions for data-driven decision making in pharma and biotech R&D. Join us at our interactive virtual office and labs to network and exchange (almost as in real life)!
In the second session of our Discngine Labs we host industry experts Wilian Cortopassi, Novartis Institute for BioMedical Research (NIBR), and Dr. Rishi Gupta, Novartis, who will present the “NIBR”Verse: the multidimensional space that brings together data and peers from all over the world in a single (virtual) place for effective collaborations in structure-based drug design.
Discngine Labs: Discngine Connector for LiveDesign®
Discngine Labs is our new exciting networking event to connect Discngine customers, partners and everyone interested in innovative solutions for data-driven decision making in pharma and biotech R&D. Join us at our interactive virtual office and labs to network and exchange (almost as in real life)!
In our first Discngine Labs session, we will present recent developments of the Discngine Connector with a special focus on the LiveDesign Connector for Spotfire, Pipeline Pilot and KNIME and their advantages for scientific projects. Then we will engage the audience in the ideation discussion chaired by Guillaume Paillard from Schrödinger, and with LiveDesign users from pharma as panelists, who will brainstorm live on the future LiveDesign integrations.